Clinical trials
Phase 1 Staphylococcal Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Jiangsu Province Centers for Disease Control and Prevention | 3 |
| Johns Hopkins University | 3 |
| Merck Sharp & Dohme LLC | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| NovaDigm Therapeutics, Inc. | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| GlaxoSmithKline | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| MedImmune LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Staphylococcal Infections | 27 |
| Communicable Diseases | 3 |
| Bacterial Infections | 2 |
| Candidiasis | 2 |
| Burns | 1 |
| Cystic Fibrosis | 1 |
| Escherichia coli Infections | 1 |
| Granulomatous Disease, Chronic | 1 |
| Infections | 1 |
| Pseudomonas Infections | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.